Reg. no. 5565718946 · Other research and experimental development on natural sciences and engineering · STOCKHOLM
Renapharma AB is registered with the legal form Limited company, is based in STOCKHOLM and is active in Other research and experimental development on natural sciences and engineering. Revenue for 2024 was 35.6 MSEK.
Fiscal year ending 2024-12-31 · Amounts in SEK
Net revenue
35.6 MSEK
▲ +18%Operating result
5.1 MSEK
▼ −24%Net result
4.1 MSEK
▼ −38%Employees (annual report)
3
Total assets
41.3 MSEK
Equity
30.6 MSEK
Equity ratio
74.1 %
Profit margin
11.6 %
MSEK
Renapharma AB reported an operating margin of 14.2 % in 2024, down from 22 %. Each of the three most recent comparable fiscal periods (2022–2024) ended in profit. In 2024, net sales corresponded to roughly 11.9 MSEK per employee (3 employees).
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Per the signatures in the annual report for the fiscal year ending 2024-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Renapharma AB's reg. no. is 5565718946.
Renapharma AB reported revenue of 35.6 MSEK for the fiscal year 2024.
Yes — Renapharma AB reported a net profit of 4.1 MSEK for 2024.
Renapharma AB had 3 employees as of the most recently reported period (2024).
Renapharma AB is registered under Other research and experimental development on natural sciences and engineering.
Renapharma AB is based in STOCKHOLM.
arkivnord